Literature DB >> 16370278

Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.

Daniel M Sciubba1, R Morgan Stuart, Matthew J McGirt, Graeme F Woodworth, Amer Samdani, Benjamin Carson, George I Jallo.   

Abstract

OBJECT: The majority of shunt infections occur within 6 months of shunt placement and chiefly result from perioperative colonization of shunt components by skin flora. Antibiotic-impregnated shunt (AIS) systems have been designed to prevent such colonization. In this study, the authors evaluate the incidence of shunt infection after introduction of an AIS system in a population of children with hydrocephalus.
METHODS: The authors retrospectively reviewed all pediatric patients who had undergone cerebrospinal fluid (CSF) shunt insertion at their institution over a 3-year period between April 2001 and March 2004. During the 18 months prior to October 2002, all CSF shunts included standard, nonimpregnated catheters. During the 18 months after October 2002, all CSF shunts included antibiotic-impregnated catheters. All patients were followed up for 6 months after shunt surgery, and all shunt-related complications, including shunt infection, were evaluated. The independent association of AIS catheter use with subsequent shunt infection was assessed via multivariate proportional hazards regression analysis. A total of 211 pediatric patients underwent 353 shunt placement procedures. In the 18 months prior to October 2002, 208 (59%) shunts were placed with nonimpregnated catheters; 145 (41%) shunts were placed with AIS catheters in the 18 months after October 2002. Of patients with nonimpregnated catheters, 25 (12%) experienced shunt infection, whereas only two patients (1.4%) with antibiotic-impregnated catheters experienced shunt infection within the 6-month follow-up period (p < 0.01). Adjusting for intercohort differences via multivariate analysis, AIS catheters were independently associated with a 2.4-fold decreased likelihood of shunt infection.
CONCLUSIONS: The AIS catheter significantly reduced incidence of CSF shunt infection in children with hydrocephalus during the early postoperative period (< 6 months). The AIS system used is an effective instrument to prevent perioperative colonization of CSF shunt components.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16370278     DOI: 10.3171/ped.2005.103.2.0131

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

1.  The impact of antibiotic-impregnated catheters on shunt infection in children and neonates.

Authors:  Caroline Hayhurst; Richard Cooke; Dawn Williams; Jothy Kandasamy; Donncha F O'Brien; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2007-10-26       Impact factor: 1.475

2.  Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.

Authors:  Scott L Parker; Frank J Attenello; Daniel M Sciubba; Giannina L Garces-Ambrossi; Edward Ahn; Jon Weingart; Benjamin Carson; George I Jallo
Journal:  Childs Nerv Syst       Date:  2008-11-05       Impact factor: 1.475

3.  Association of intraventricular hemorrhage secondary to prematurity with cerebrospinal fluid shunt surgery in the first year following initial shunt placement.

Authors:  Tamara D Simon; Kathryn B Whitlock; Jay Riva-Cambrin; John R W Kestle; Margaret Rosenfeld; J Michael Dean; Richard Holubkov; Marcie Langley; Nicole Mayer-Hamblett
Journal:  J Neurosurg Pediatr       Date:  2012-01       Impact factor: 2.375

Review 4.  Ventriculoperitoneal shunt as a primary neurosurgical procedure in newborn posthemorrhagic hydrocephalus: report of a series of 47 shunted patients.

Authors:  L Romero; B Ros; F Ríus; L González; J M Medina; A Martín; A Carrasco; M A Arráez
Journal:  Childs Nerv Syst       Date:  2013-07-24       Impact factor: 1.475

5.  Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Authors:  Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano
Journal:  J Neurosurg       Date:  2018-08-03       Impact factor: 5.115

6.  Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years.

Authors:  Joon Kee Lee; Joon Young Seok; Joon Ho Lee; Eun Hwa Choi; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang; Hoan Jong Lee
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

7.  Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.

Authors:  Raquel Gutiérrez-González; Gregorio R Boto; Cristina Fernández-Pérez; Náyade del Prado
Journal:  BMC Neurol       Date:  2010-10-12       Impact factor: 2.474

8.  Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures.

Authors:  Benoit J M Pirotte; Alphonse Lubansu; Michael Bruneau; Chakir Loqa; Nathalie Van Cutsem; Jacques Brotchi
Journal:  Childs Nerv Syst       Date:  2007-08-18       Impact factor: 1.475

9.  Revision surgeries are associated with significant increased risk of subsequent cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Kathryn B Whitlock; Jay Riva-Cambrin; John R W Kestle; Margaret Rosenfeld; J Michael Dean; Richard Holubkov; Marcie Langley; Nicole Mayer Hamblett
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

10.  Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis N Shannon; Mandeep Tamber; John C Wellons Iii; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatric Infect Dis Soc       Date:  2019-07-01       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.